Morphine-Tolerant Mice Exhibit a Profound and Persistent Cardioprotective Phenotype

Circulation

Volumn 109, Issue 10, 2004, Pages 1219-1222

  Peart, Jason N ^a   Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Ischemia; Myocardial infarction; Myocardial stunning; Occlusion; Reperfusion

Indexed keywords

LACTATE DEHYDROGENASE; MORPHINE; PLACEBO;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART PROTECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MORPHINE ADDICTION; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PAIN; PHENOTYPE; PRIORITY JOURNAL; STUNNED HEART MUSCLE;

ANIMALS; CARDIOTONIC AGENTS; DRUG IMPLANTS; DRUG TOLERANCE; HEART; MALE; MICE; MICE, INBRED C57BL; MORPHINE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; PAIN MEASUREMENT; PHENOTYPE; REACTION TIME; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA;

EID: 1642326902     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000121422.85989.BD     Document Type: Article

References (23)

1. Bell SP, Sack MN, Patel A, et al. Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol. 2001;36:296-302.
2. Schultz JE, Gross GJ. Opioids and cardioprotection. Pharmacol Ther. 2001;89:123-137.
3. Gross RA, Moises HC, Uhler MD et al. Dynorphin A and cAMP-dependent protein kinase independently regulate neuronal calcium currents. Proc Natl Acad Sci U S A. 1990;87:7025-7029.
4. North RA, Williams JT, Surprenant A, et al. Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci U S A. 1987;84:5487-5491.
5. Weil J, Eschenhagen T, Fleige G, et al. Localization of preproenkephalin mRNA in rat heart: selective gene expression in left ventricular myocardium. Am J Physiol. 1998;275:H378-H384.
6. Schultz J el-J, Hsu AK, Nagase H, et al. TAN-67, a delta 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels. Am J Physiol. 1998;274:H909-H914.
7. Miki T, Cohen MV, Downey JM. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem. 1998;186:3-12.
8. Schultz JE, Rose E, Yao Z, et al. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol. 1995;268:H2157-H2161.
9. Peart J, Willems L, Headrick JP. Receptor and non-receptor-dependent mechanisms of cardioprotection with adenosine. Am J Physiol. 2003;284: H519-H527.
10. Dewey WL, Harris LS, Howes JF, et al. The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J Pharmacol Exp Ther. 1970;175:435-442.
11. Bryant HU, Yobum BC, Inturrisi CE, et al. Morphine-induced immunomodulation is not related to serum morphine concentrations. Eur J Pharmacol. 1988;149:165-169.
12. Fryer RM, Hsu AK, Eells JT, et al. Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels. Circ Res. 1999;84:846-851.
13. Kodani E, Xuan YT, Shinmura K, et al. Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits. Am J Physiol. 2002;283:H1943-H1957.
14. Tsuchida A, Thompson R, Olsson RA, et al. The anti-infarct effect of an adenosine agonist is diminished after prolonged infusion as is the cardioprotective effect of ischaemic preconditioning in rabbit heart. J Mol Cell Cardiol. 1994;26:303-311.
15. Dana A, Baxter GF, Walker JM, et al. Prolonging the delayed phase of myocardial protection: repetitive adenosine Al receptor activation maintains rabbit myocardium in a preconditioned state. J Am Coll Cardiol. 1998;31:1142-1149.
16. Cohen MV, Yang XM, Downey JM. Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning. Circ Res. 1994;74:998-1004.
17. Harrison GJ, Willis RJ, Headrick JP. Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart. Cardiovasc Res. 1998;40:74-87.
18. Eisinger DA, Ammer H, Schulz R. Chronic morphine treatment inhibits opioid receptor desensitization and internalization. J Neurosci. 2002;22:10192-10200.
19. Trang T, Sutak M, Quirion R, et al. The role of spinal neuropeptides and prostaglandins in opioid physical dependence. Br J Pharmacol. 2002;136:37-48.
20. Halimi G, Devaux C, Clot-Faybesse O, et al. Modulation of adenosine concentration by opioid receptor agonists in rat striatum. Eur J Pharmacol. 2000;398:217-224.
21. Brundege JM, Williams JT. Increase in adenosine sensitivity in the nucleus accumbens following chronic morphine treatment. J Neurophysiol. 2002;87:1369-1375.
22. Crain SM, Shen KF. After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside. Brain Res. 1992;575:13-24.
23. Varga EV, Yamamura HI, Rubenzik MK, et al. Molecular mechanisms of excitatory signaling upon chronic opioid agonist treatment. Life Sci. 2003;74:299-311.